Over several months, the redness fades. The area takes on the color of the surrounding mucosa, often appearing as a pale, white scar with radiating mucosal folds. Clinical Significance
Patients staged within 48 hours of fever onset who receive stage-appropriate therapy (e.g., early ribavirin for Stage I; plasma exchange for Stage III) have a 54% relative risk reduction in progression to Stage IV (NNT = 6). Importantly, the Classification also identifies a subset of (> 5,000 ng/mL) – termed "Sakitamiwa Macrophage Activation Syndrome" – which responds to anakinra (IL-1 blockade) but not corticosteroids.
This classification is a critical tool in clinical trials to evaluate the efficacy of acid-suppressing drugs like Proton Pump Inhibitors (PPIs) and Potassium-Competitive Acid Blockers (P-CABs) .
This comprehensive article will explore the history and core principles of the Sakita-Miwa classification, provide a detailed breakdown of its six stages, and examine its wide-ranging clinical applications. sakitamiwa classification
The Sakita-Miwa classification is a proven and standardized endoscopic system for describing the natural healing stages of gastric ulcers. It remains a vital tool in daily clinical practice, clinical research, and medical education by providing a universal language to assess, communicate, and monitor this common condition.
While originally designed for gastric ulcers, modified versions of this classification are now used to evaluate ulcer activity in intestinal Behçet's disease, focusing on edema and white-plaque adhesion. 4. Importance in Modern Gastroenterology
The Sakita–Miwa classification system splits the lifecycle of an ulcer into three major chronological steps, with each phase further sub-divided into two precise micro-stages. Over several months, the redness fades
As treatment progresses, the ulcer enters the healing phase, characterized by the gradual reduction of the slough and the appearance of regenerative tissue.
The coating becomes thinner, and the ulcer size significantly decreases. Regenerative epithelium appears, forming a white or reddish border around the ulcer margin.
The system is frequently used to monitor the healing of artificial ulcers created after endoscopic submucosal dissection. Importantly, the Classification also identifies a subset of
The is a standard endoscopic staging system used to evaluate the healing process of gastric and duodenal ulcers. It divides ulcer progression into three main stages (Active, Healing, and Scarring), with each further subdivided into two levels. Classification Stages The system uses the following six-stage categorical scale: Stage Description A1 Acute phase; thick white coating (slough) and sharp edges. A2
| Feature | | Modified Sakita-Miwa | Forrest Classification | | :--- | :--- | :--- | :--- | | Primary Purpose | Staging the natural history of an ulcer's healing process | Adapted version for specific contexts (e.g., post-band ligation ulcers) | Assessing the risk of re-bleeding from an ulcer | | Key Focus | Presence of fibrin slough, regenerating epithelium, scarring | Often customized definitions, but based on the core A-H-S framework | Presence and type of stigmata of recent hemorrhage (e.g., active bleeding, visible vessel, clot) | | Main Application | Assessing ulcer activity, healing, and completeness of mucosal repair | Research or specialized clinical scenarios (e.g., variceal banding ulcers) | Emergency and acute management of upper GI bleeding | | Stages | A1, A2, H1, H2, S1, S2 (6 stages) | Varies; often focuses on healing stages (e.g., H1, H2, S1) | Ia (spurting), Ib (oozing), IIa (visible vessel), IIb (adherent clot), IIc (flat spot), III (clean base) |
The ulcer becomes significantly smaller and shallower. The regenerating epithelium covers more of the base, and the white coating is significantly reduced. 3. Scarring Stage (Stage S) The ulcer has essentially closed, leaving behind a scar.
Ulcer is very small and shallow; regeneration dominates the floor S1